期刊文献+

丹参注射液联合复方甘草酸苷治疗慢性乙肝疗效观察 被引量:3

丹参注射液联合复方甘草酸苷治疗慢性乙肝疗效观察
下载PDF
导出
摘要 目的:观察丹参注射液联合复方甘草酸苷治疗慢性乙型肝炎肝功能及肝纤维化指标的影响。方法:136例慢性乙肝患者随即分成两组。治疗组70例用丹参注射液联合复方甘草酸苷,对照组66例用还原型谷胱甘肽注射液,两组均为1个月,观察其肝功能及肝纤维化指标的变化。结果:治疗组对肝功能及肝纤维化指标方面明显优于对照组(P<0.01)。结论:丹参注射液联合复方甘草酸苷联合用药治疗慢性乙型肝炎患方具有良好的抗纤维化疗效。 Objective: To observe thejoint compound danshen injection nucleoside glycyrrhizic acid treatment of chronic hepatitis b liver function and influence of liver fibrosis indices. Methods : 136 patients with chronic hepatitis b then divided into two groups. 70 cases in treatment group with joint compound danshen injection, glycyrrhizic acid group in 66 patients with reduced glutathione injection, both groups for a month, observe the liver and liver fibrosis indices of change. Results the treatment group of liver fibrosis and index than control group (P 〈 0. 01 ). Conclusion: HDP injection joint compound glycyrrhizic acid nucleoside combination therapy for chronic hepatitis b with square has good anti fibrosis curative effect.
出处 《中国社区医师(医学专业)》 2010年第24期120-120,共1页
关键词 慢性乙型肝炎 复方甘草酸苷 丹参注射液 肝纤维化指标 chronic hepatitis b compound danshen nucleoside glycyrrhizic acid injection liver fibrosis indices
  • 相关文献

参考文献3

二级参考文献3

共引文献14023

同被引文献38

  • 1唐倩青,闫志勇,王斌.AST/ALT、HBeAg与单纯HBV感染疾病的关系[J].临床和实验医学杂志,2007,6(3):3-4. 被引量:6
  • 2秦金环,孙艳华,马金英.复方甘草酸苷联合丹参注射液治疗慢性乙型肝炎的疗效[J].中国医药导报,2007,4(04Z):67-68. 被引量:3
  • 3中华医学会肝病学分会,感染病学分会.慢性乙型肝炎防治指南(2010年版)[J].胃肠病学,2011,16(16):351-366.
  • 4何义华,潘志恒,李林,关卫兵,王拥泽,李永伟,杨跃武.中药辨证治疗中重度慢性乙肝临床疗效对照分析[J].世界华人消化杂志,2007,15(28):3006-3010. 被引量:7
  • 5Bums GS, Thompson AJ. Viral hepatitis B: clinical and epidemi- dagical characteristics [ J ]. Cold Spring Harb Perspect Med, 2014, 4(12) : a024935.
  • 6Chang MH. Hepatitis B virus and cancer prevention [ J ]. Recent Results Cancer Res, 2011, 188: 75-84.
  • 7Huang Q, Huang R, Wei L, et al. Antiviral activity of methyl he- licterate isolated from Helicteres angustifolia (Sterculiaceae) against hepatitis B virus[J]. Antiviral Res, 2013, 100(2) : 373- 381.
  • 8Ayres A, Bartholoareusz A, Lau G, et al. Lamivudine and Famci- clovir resistant hepatitis B virus associated with fatal hepatic failnre [J]. J Clin Virol, 2003, 27(1) : 111-116.
  • 9Berger A, Preiser W, Doerr HW. The rule of viral load determina- tion for the management of human immunodeficiency virus, hepati- tis B virus and hepatitis C virus infection[ J]. J Clin Virul, 2001, 20(1-2) : 23-30.
  • 10European Association For The Study Of The Liver. EASL clinical practice guidelines : Management of chronic hepatitis B virus infec- tion[J].J Hepatol, 2012, 57(1 ) : 167-185.

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部